Category Archives: The IPO Buzz

More stock – priced at the mid-point: Maze Therapeutics (MAZE), a biotech developing drugs to treat chronic kidney disease (CKD), increased its IPO’s size – to 8.75 million shares – up from 7.8 million shares in the prospectus – and priced its IPO at $16.00 – the mid-point of its $15.00-to-$17.00 price range – to raise […]

Metsera (MTSR), the developer of a weight-loss shot, priced its IPO at $18.00 – $1.00 above the top of its $15.00-to-$17.00 price range – on Thursday night, Jan. 30, 2025. The New York biotech, however, trimmed the IPO’s size at pricing to 15.28 million shares – down from 17.19 million shares in the prospectus – […]

Infinity Natural Resources (INR), an oil and natural gas producer involved in fracking in Ohio and Pennsylvania, priced its IPO at $20.00 – $1.00 below the top of its $18.00-to-$21.00 price range – on Thursday night, Jan. 30, 2025. Infinity Natural Resources sold 13.25 million shares – the number of shares in the prospectus – at […]

Insulin delivery device maker Beta Bionics (BBNX) increased its IPO’s size to 12.0 million shares – up from 10.0 million shares – and priced the IPO at $17.00 – the top of its range – to raise $204.0 million on Wednesday night, Jan. 29, 2025. At pricing, Beta Bionics had a market cap of $729.13 million. (This column, […]

FG Merger II Corp. (FGMCU) priced its small SPAC IPO – 8.0 million units at $10.00 each – and raised $80.0 million on Tuesday night, Jan. 28, 2025.This financial services-focused SPAC IPO is among three SPAC IPOs on tap this week. If all three SPAC IPO deals get done, they will  raise $430 million in […]

Titan America SA (TTAM Proposed), the leading manufacturer and supplier of cement, concrete and other heavy building materials serving the metro New York area and the U.S. Eastern Seaboard, disclosed the terms for its $396 million IPO – 24.0 million shares at a price range of $15.00 to $18.00 – in an F-1/A filing early […]

Smithfield Foods (SFD) priced its IPO at $20.00 – $3.00 below the $23.00-to-$27.00 range in the prospectus – and cut the IPO’s size at pricing to about 26.09 million shares – down from 34.8 million shares in the prospectus – to raise $521.74 million on Monday night, Jan. 27, 2025. (This column, published early Tuesday, […]

Chronic kidney disease-focused Maze Therapeutics (MAZE Proposed) disclosed the terms for its $124.8 million IPO early today – Monday, Jan. 27, 2025 – and launched the deal to price this week. Maze Therapeutics plans to offer 7.8 million shares at a price range of $15.00 to $17.00 to raise $124.8 million, if priced at the […]

LNG producer Venture Global (VG) priced its IPO at $25.00 – the mid-point of its recently lowered price range of $23.00 to $27.00 – and sold all 70.0 million shares – the number of shares in the prospectus – to raise $1.75 billion on Thursday night, Jan. 23, 2025. At pricing, the market cap was $60.5 billion. […]

Venture Global (VG Proposed) slashed its price range to $23.00 to $27.00 – down from $40.00 to $46.00 – and increased the number of shares to 70.0 million shares – up from 50.0 million shares – to raise $1.75 billion, according to an S-1/A filing early today – Wednesday, Jan. 22, 2025. The sharp cut […]